INNOVATE BIOPHARMACEUTICALS INC

INNT NASDAQ
1.100
-0.030
-2.65%
Closed 16:00 07/23 EDT
Open
1.130
Prev Close
1.130
High
1.130
Low
1.080
Volume
228.18K
Avg Vol (3M)
822.82K
52 Week High
9.68
52 Week Low
1.070
% Turnover
8.88%
Market Cap
2.83M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers INNOVATE BIOPHARMACEUTICALS INC INNT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Innovate Biopharmaceuticals, Inc., formerly Monster Digital, Inc., is a clinical stage biotechnology company. The Company is focused on developing novel autoimmune and inflammation therapeutic drugs. Its lead drug candidate, larazotide acetate (INN-202) is a tight junction regulator. Its other products include INN-108 and INN-329 (Secretin). The Company’s INN-108 is a novel small molecule comprised of two active parts with anti- inflammatory and immunodulatory properties coupled through an azo bond. The Company is developing INN-108 as a therapeutic for Ulcerative Colitis (UC). Its Secretin stimulated magnetic resonance cholangiopancreatography (MRCP) is a ionizing, radiation-free assessment of the pancreaticobiliary system. The Company has completed a phase II b clinical trial for celiac disease for INN-202. It is developing INN-108 in a phase II trial for inflammatory bowel disorders, mild to moderate UC and a Gastrointestinal (GI) orphan disease.
MORE >

Recently

Name
Price
%Change